|
CHEMBL2581
|
P07339
|
Cathepsin D |
99.70%
|
98.95%
|
|
CHEMBL1795139
|
Q8IU80
|
Transmembrane protease serine 6 |
99.27%
|
98.33%
|
|
CHEMBL220
|
P22303
|
Acetylcholinesterase |
99.07%
|
94.45%
|
|
CHEMBL237
|
P41145
|
Kappa opioid receptor |
98.84%
|
98.10%
|
|
CHEMBL230
|
P35354
|
Cyclooxygenase-2 |
98.35%
|
89.63%
|
|
CHEMBL236
|
P41143
|
Delta opioid receptor |
98.25%
|
99.35%
|
|
CHEMBL4979
|
P13866
|
Sodium/glucose cotransporter 1 |
98.07%
|
98.24%
|
|
CHEMBL4801
|
P29466
|
Caspase-1 |
97.82%
|
96.85%
|
|
CHEMBL4394
|
Q9NYA1
|
Sphingosine kinase 1 |
97.71%
|
96.03%
|
|
CHEMBL2514
|
O95665
|
Neurotensin receptor 2 |
97.21%
|
100.00%
|
|
CHEMBL335
|
P18031
|
Protein-tyrosine phosphatase 1B |
96.96%
|
95.17%
|
|
CHEMBL3130
|
O00329
|
PI3-kinase p110-delta subunit |
96.67%
|
96.47%
|
|
CHEMBL2107
|
P61073
|
C-X-C chemokine receptor type 4 |
96.47%
|
93.10%
|
|
CHEMBL3251
|
P19838
|
Nuclear factor NF-kappa-B p105 subunit |
96.26%
|
96.09%
|
|
CHEMBL2730
|
P21980
|
Protein-glutamine gamma-glutamyltransferase |
95.73%
|
92.38%
|
|
CHEMBL204
|
P00734
|
Thrombin |
95.70%
|
96.01%
|
|
CHEMBL221
|
P23219
|
Cyclooxygenase-1 |
95.59%
|
90.17%
|
|
CHEMBL3359
|
P21462
|
Formyl peptide receptor 1 |
95.21%
|
93.56%
|
|
CHEMBL2492
|
P36544
|
Neuronal acetylcholine receptor protein alpha-7 subunit |
94.88%
|
88.42%
|
|
CHEMBL4018
|
P49146
|
Neuropeptide Y receptor type 2 |
94.47%
|
98.94%
|
|
CHEMBL4026
|
P40763
|
Signal transducer and activator of transcription 3 |
94.16%
|
82.69%
|
|
CHEMBL4777
|
P25929
|
Neuropeptide Y receptor type 1 |
94.15%
|
96.67%
|
|
CHEMBL3807
|
P17706
|
T-cell protein-tyrosine phosphatase |
93.16%
|
93.00%
|
|
CHEMBL340
|
P08684
|
Cytochrome P450 3A4 |
93.14%
|
91.19%
|
|
CHEMBL1907591
|
P30926
|
Neuronal acetylcholine receptor; alpha4/beta4 |
92.91%
|
100.00%
|
|
CHEMBL3137262
|
O60341
|
LSD1/CoREST complex |
92.55%
|
97.09%
|
|
CHEMBL4588
|
P22894
|
Matrix metalloproteinase 8 |
92.45%
|
94.66%
|
|
CHEMBL274
|
P51681
|
C-C chemokine receptor type 5 |
92.20%
|
98.77%
|
|
CHEMBL4123
|
P30989
|
Neurotensin receptor 1 |
91.90%
|
96.67%
|
|
CHEMBL1873
|
P00750
|
Tissue-type plasminogen activator |
91.48%
|
93.33%
|
|
CHEMBL4361
|
Q07820
|
Induced myeloid leukemia cell differentiation protein Mcl-1 |
91.33%
|
95.52%
|
|
CHEMBL4657
|
Q6V1X1
|
Dipeptidyl peptidase VIII |
91.05%
|
97.21%
|
|
CHEMBL4625
|
Q07817
|
Apoptosis regulator Bcl-X |
89.98%
|
99.77%
|
|
CHEMBL1914
|
P06276
|
Butyrylcholinesterase |
89.89%
|
95.00%
|
|
CHEMBL3024
|
P53350
|
Serine/threonine-protein kinase PLK1 |
89.74%
|
97.43%
|
|
CHEMBL1944495
|
P28065
|
Proteasome subunit beta type-9 |
89.53%
|
97.50%
|
|
CHEMBL4816
|
Q9Y243
|
Serine/threonine-protein kinase AKT3 |
89.01%
|
96.28%
|
|
CHEMBL3837
|
P07711
|
Cathepsin L |
88.96%
|
96.61%
|
|
CHEMBL4203
|
Q9HAZ1
|
Dual specificity protein kinase CLK4 |
88.93%
|
94.45%
|
|
CHEMBL2073
|
P07947
|
Tyrosine-protein kinase YES |
88.79%
|
83.14%
|
|
CHEMBL2534
|
O15530
|
3-phosphoinositide dependent protein kinase-1 |
88.76%
|
95.36%
|
|
CHEMBL5845
|
P23415
|
Glycine receptor subunit alpha-1 |
88.71%
|
90.71%
|
|
CHEMBL3176
|
O43603
|
Galanin receptor 2 |
88.59%
|
98.89%
|
|
CHEMBL3392948
|
Q9NP59
|
Solute carrier family 40 member 1 |
88.25%
|
95.00%
|
|
CHEMBL3468
|
P55210
|
Caspase-7 |
88.18%
|
95.68%
|
|
CHEMBL5619
|
P27695
|
DNA-(apurinic or apyrimidinic site) lyase |
87.74%
|
91.11%
|
|
CHEMBL4227
|
P25090
|
Lipoxin A4 receptor |
87.30%
|
100.00%
|
|
CHEMBL1907600
|
Q00535
|
Cyclin-dependent kinase 5/CDK5 activator 1 |
87.00%
|
93.03%
|
|
CHEMBL3437
|
Q16853
|
Amine oxidase, copper containing |
86.98%
|
94.00%
|
|
CHEMBL3018
|
Q9Y5Y6
|
Matriptase |
86.78%
|
98.33%
|
|
CHEMBL2413
|
P32246
|
C-C chemokine receptor type 1 |
86.76%
|
89.50%
|
|
CHEMBL253
|
P34972
|
Cannabinoid CB2 receptor |
86.34%
|
97.25%
|
|
CHEMBL1075094
|
Q16236
|
Nuclear factor erythroid 2-related factor 2 |
86.20%
|
96.00%
|
|
CHEMBL4685
|
P14902
|
Indoleamine 2,3-dioxygenase |
85.45%
|
96.38%
|
|
CHEMBL3060
|
Q9Y345
|
Glycine transporter 2 |
85.43%
|
99.17%
|
|
CHEMBL3267
|
P48736
|
PI3-kinase p110-gamma subunit |
85.17%
|
95.71%
|
|
CHEMBL283
|
P08254
|
Matrix metalloproteinase 3 |
84.14%
|
97.29%
|
|
CHEMBL5701
|
Q9H2K8
|
Serine/threonine-protein kinase TAO3 |
83.60%
|
96.67%
|
|
CHEMBL233
|
P35372
|
Mu opioid receptor |
83.56%
|
97.93%
|
|
CHEMBL1795117
|
Q8TEK3
|
Histone-lysine N-methyltransferase, H3 lysine-79 specific |
83.49%
|
93.56%
|
|
CHEMBL3238
|
P23786
|
Carnitine palmitoyltransferase 2 |
83.19%
|
94.05%
|
|
CHEMBL259
|
P32245
|
Melanocortin receptor 4 |
82.98%
|
95.38%
|
|
CHEMBL5103
|
Q969S8
|
Histone deacetylase 10 |
82.97%
|
90.08%
|
|
CHEMBL2781
|
P19634
|
Sodium/hydrogen exchanger 1 |
82.52%
|
90.24%
|
|
CHEMBL2111367
|
P27986
|
PI3-kinase p110-alpha/p85-alpha |
82.42%
|
94.33%
|
|
CHEMBL4246
|
P42680
|
Tyrosine-protein kinase TEC |
82.32%
|
82.05%
|
|
CHEMBL5261
|
Q7L7X3
|
Serine/threonine-protein kinase TAO1 |
82.27%
|
89.33%
|
|
CHEMBL1907594
|
P30926
|
Neuronal acetylcholine receptor; alpha3/beta4 |
82.15%
|
97.23%
|
|
CHEMBL5203
|
P33316
|
dUTP pyrophosphatase |
82.01%
|
99.18%
|
|
CHEMBL4187
|
Q99250
|
Sodium channel protein type II alpha subunit |
81.76%
|
95.50%
|
|
CHEMBL4040
|
P28482
|
MAP kinase ERK2 |
81.30%
|
83.82%
|
|
CHEMBL249
|
P25103
|
Neurokinin 1 receptor |
81.15%
|
99.17%
|
|
CHEMBL5608
|
Q16288
|
NT-3 growth factor receptor |
81.15%
|
95.89%
|
|
CHEMBL2693
|
Q9UIQ6
|
Cystinyl aminopeptidase |
80.83%
|
97.64%
|
|
CHEMBL4478
|
Q00975
|
Voltage-gated N-type calcium channel alpha-1B subunit |
80.83%
|
97.14%
|
|
CHEMBL4618
|
P09960
|
Leukotriene A4 hydrolase |
80.82%
|
97.86%
|
|
CHEMBL4101
|
P17612
|
cAMP-dependent protein kinase alpha-catalytic subunit |
80.67%
|
82.86%
|
|
CHEMBL5028
|
O14672
|
ADAM10 |
80.56%
|
97.50%
|
|
CHEMBL4198
|
P98170
|
Inhibitor of apoptosis protein 3 |
80.27%
|
97.79%
|